INR 688.55
(0.19%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.17 Billion INR | 11.35% |
2022 | 1.94 Billion INR | 18.71% |
2021 | 1.64 Billion INR | -0.36% |
2020 | 1.64 Billion INR | 10.84% |
2019 | 1.48 Billion INR | 9.51% |
2018 | 1.35 Billion INR | 4.6% |
2017 | 1.29 Billion INR | -8.97% |
2016 | 1.42 Billion INR | -10.47% |
2015 | 1.59 Billion INR | 3.28% |
2014 | 1.54 Billion INR | -1.3% |
2013 | 1.56 Billion INR | 2.13% |
2012 | 1.53 Billion INR | -1.98% |
2011 | 1.56 Billion INR | 14.18% |
2010 | 1.36 Billion INR | 10.94% |
2009 | 1.23 Billion INR | 0.38% |
2008 | 1.22 Billion INR | -5.74% |
2007 | 1.3 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2024 Q2 | 2.58 Billion INR | 0.0% |
2023 Q2 | 2.09 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 2.17 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 2.17 Billion INR | 11.35% |
2022 FY | 1.94 Billion INR | 18.71% |
2022 Q4 | 1.94 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 1.65 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 1.64 Billion INR | -0.36% |
2021 Q4 | 1.64 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 1.92 Billion INR | 0.0% |
2020 FY | 1.64 Billion INR | 10.84% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 1.63 Billion INR | 0.0% |
2020 Q4 | 1.64 Billion INR | 0.0% |
2019 Q2 | 1.45 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 1.48 Billion INR | 9.51% |
2019 Q4 | 1.48 Billion INR | 0.0% |
2018 FY | 1.35 Billion INR | 4.6% |
2018 Q4 | 1.35 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 1.27 Billion INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 FY | 1.29 Billion INR | -8.97% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 1.29 Billion INR | 0.0% |
2017 Q4 | 1.29 Billion INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 FY | 1.42 Billion INR | -10.47% |
2016 Q4 | 1.42 Billion INR | 0.0% |
2016 Q2 | 1.66 Billion INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 1.55 Billion INR | 0.0% |
2015 Q4 | 1.59 Billion INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 FY | 1.59 Billion INR | 3.28% |
2014 Q2 | 1.59 Billion INR | 0.0% |
2014 FY | 1.54 Billion INR | -1.3% |
2014 Q4 | 1.54 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2013 FY | 1.56 Billion INR | 2.13% |
2013 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 1.52 Billion INR | 0.0% |
2013 Q4 | 1.56 Billion INR | 0.0% |
2012 FY | 1.53 Billion INR | -1.98% |
2012 Q4 | 1.53 Billion INR | 0.0% |
2012 Q2 | 1.55 Billion INR | 0.0% |
2011 Q4 | 1.56 Billion INR | 0.0% |
2011 Q2 | - INR | 0.0% |
2011 FY | 1.56 Billion INR | 14.18% |
2010 FY | 1.36 Billion INR | 10.94% |
2009 FY | 1.23 Billion INR | 0.38% |
2008 FY | 1.22 Billion INR | -5.74% |
2007 FY | 1.3 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Ajanta Pharma Limited | 46.38 Billion INR | 95.32% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 40.83% |
Sigachi Industries Limited | 6.94 Billion INR | 68.728% |
Bal Pharma Limited | 3.2 Billion INR | 32.245% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 81.368% |
Medico Remedies Limited | 961.95 Million INR | -125.664% |
Lasa Supergenerics Limited | 1.5 Billion INR | -43.885% |
Venus Remedies Limited | 6.26 Billion INR | 65.369% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 57.852% |
Alpa Laboratories Limited | 1.82 Billion INR | -18.868% |
Nectar Lifesciences Limited | 21.91 Billion INR | 90.093% |
Shilpa Medicare Limited | 30.93 Billion INR | 92.982% |
Aarti Drugs Limited | 24.32 Billion INR | 91.075% |
Lupin Limited | 239.97 Billion INR | 99.095% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.518% |
Zydus Lifesciences Limited | 292.8 Billion INR | 99.259% |
Windlas Biotech Limited | 6.26 Billion INR | 65.334% |
Suven Life Sciences Limited | 2.84 Billion INR | 23.806% |
Eris Lifesciences Limited | 70.48 Billion INR | 96.92% |
Valiant Laboratories Limited | 3.42 Billion INR | 36.654% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 94.565% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 90.766% |
Ipca Laboratories Limited | 111.01 Billion INR | 98.045% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 82.117% |
Achyut Healthcare Limited | 309.52 Million INR | -601.333% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.746% |
Bajaj HealthCare Limited | 7.65 Billion INR | 71.629% |
RPG Life Sciences Limited | 5.12 Billion INR | 57.674% |
Mankind Pharma Limited | 119.63 Billion INR | 98.185% |
Laurus Labs Limited | 83.87 Billion INR | 97.412% |
Piramal Pharma Limited | 153.11 Billion INR | 98.582% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 46.356% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 98.559% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 96.632% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 98.488% |
Unichem Laboratories Limited | 31.69 Billion INR | 93.151% |
Sequent Scientific Limited | 15.4 Billion INR | 85.908% |
Novartis India Limited | 9.24 Billion INR | 76.53% |
Wanbury Limited | 3.43 Billion INR | 36.803% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 90.37% |
Wockhardt Limited | 76.49 Billion INR | 97.162% |
Themis Medicare Limited | 5.66 Billion INR | 61.675% |
Jubilant Pharmova Limited | 115.48 Billion INR | 98.12% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 92.384% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.44% |
Divi's Laboratories Limited | 154.7 Billion INR | 98.597% |
NATCO Pharma Limited | 69.06 Billion INR | 96.857% |
Gufic Biosciences Limited | 10.92 Billion INR | 80.131% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 90.328% |
Ind-Swift Limited | 6.54 Billion INR | 66.832% |
Procter & Gamble Health Limited | 7.94 Billion INR | 72.673% |
FDC Limited | 24.68 Billion INR | 91.205% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -21.834% |
Granules India Limited | 55.2 Billion INR | 96.068% |
Medicamen Biotech Limited | 2.94 Billion INR | 26.295% |
Alkem Laboratories Limited | 155.74 Billion INR | 98.606% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 79.863% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -361.057% |
Brooks Laboratories Limited | 904.45 Million INR | -140.01% |
Megasoft Limited | 3.65 Billion INR | 40.673% |
ZIM Laboratories Limited | 4.46 Billion INR | 51.417% |
Strides Pharma Science Limited | 58.39 Billion INR | 96.283% |
Neuland Laboratories Limited | 18.32 Billion INR | 88.154% |
Morepen Laboratories Limited | 12.93 Billion INR | 83.214% |
Hikal Limited | 24.87 Billion INR | 91.272% |
Indoco Remedies Limited | 21.44 Billion INR | 89.879% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 91.593% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | 9.574% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 34.894% |
Hester Biosciences Limited | 6.62 Billion INR | 67.226% |